Perinatal HIV exposure is associated with long-term alterations in immune marker levels in children

José Avendaño-Ortiz1, Judit Ventosa-Cubillo2, Concepción Rodríguez-Jiménez2

  • 1Hospital Universitario Ramón y Cajal, and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain; CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain.

Insights

Perinatal HIV exposure causes lasting immune changes in uninfected children, affecting cytokines and inflammation markers. These alterations may increase their risk for future health issues.

Area of Science:

  • Immunology
  • Pediatrics
  • Infectious Diseases

Background:

  • HIV-exposed uninfected (HEU) children are a growing population with poorly understood long-term immune effects.
  • Perinatal HIV exposure may lead to persistent immune alterations in children who do not contract HIV.

Purpose of the Study:

  • To investigate long-term immune alterations in HIV-exposed uninfected (HEU) children.
  • To compare immune biomarkers in HEU children with HIV-unexposed uninfected (HUU) children and HIV-exposed infected (HEI) children.

Main Methods:

  • A prospective cohort study of 91 children (<13 years) in Mexico.
  • Classification into four groups: HUU (n=25), HEU (n=25), HEI with undetectable viral load (HEIundetVL, n=25), and HEI with detectable viral load (HEIdetVL, n=16).
  • Measurement of 64 immune biomarkers (55 plasma proteins, 9 blood mRNAs).

Main Results:

  • HEU children showed distinct immune profiles compared to HUU children, with higher IL-17A, TIM-3, P-Selectin, and CD14 mRNA, and lower SAA, IGFBP-4, myeloperoxidase, and tPA.
  • HEU children exhibited higher inter-individual variability in immune markers than HUU children.
  • Active HIV infection (HEIdetVL) was associated with significant immune dysregulation, affecting 15 markers including myeloid activation, chemokines, and coagulation factors, compared to HEIundetVL.

Conclusions:

  • Perinatal HIV exposure induces persistent immune alterations in children, even if they remain uninfected.
  • These alterations include elevated cytokines, immune-checkpoints, and markers of thrombosis and vascular inflammation.
  • These immunological imprints may contribute to an increased risk of adverse health outcomes in HEU children.
Abstract

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.7K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
336
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.0K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.1K